Verena Fetz

3.1k total citations · 1 hit paper
27 papers, 2.5k citations indexed

About

Verena Fetz is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Verena Fetz has authored 27 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Molecular Medicine. Recurrent topics in Verena Fetz's work include Antibiotic Resistance in Bacteria (5 papers), Nuclear Structure and Function (4 papers) and Cancer-related Molecular Pathways (4 papers). Verena Fetz is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Nuclear Structure and Function (4 papers) and Cancer-related Molecular Pathways (4 papers). Verena Fetz collaborates with scholars based in Germany, United States and China. Verena Fetz's co-authors include Roland H. Stauber, Shirley K. Knauer, Stefan Tenzer, Michael Maskos, Katharina Landfester, Dominic Docter, Hansjörg Schild, Christoph Reinhardt, Klytaimnistra Kiouptsi and Anna Musyanovych and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Environmental Science & Technology.

In The Last Decade

Verena Fetz

26 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

2013 1.8k citations Stefan Tenzer, Dominic Docter et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Verena Fetz Germany	16	1.1k	1.0k	742	570	276	27	2.5k
Zhou J. Deng United States	19	1.3k 1.3×	1.2k 1.1×	877 1.2×	696 1.2×	388 1.4×	30	2.8k
Delyan R. Hristov Ireland	13	1.2k 1.2×	1.0k 1.0×	939 1.3×	503 0.9×	258 0.9×	18	2.3k
Mingtao Liang Australia	22	975 0.9×	792 0.8×	618 0.8×	607 1.1×	232 0.8×	58	2.2k
Christopher B. McLeland United States	9	864 0.8×	808 0.8×	594 0.8×	537 0.9×	153 0.6×	9	2.1k
Jonathan B. Olsen Canada	14	1.4k 1.4×	1.3k 1.3×	918 1.2×	802 1.4×	345 1.3×	17	3.0k
Federico Fenaroli Norway	19	875 0.8×	746 0.7×	714 1.0×	697 1.2×	168 0.6×	30	2.3k
James O. Blanchette United States	15	1.6k 1.5×	1.1k 1.1×	1.3k 1.7×	434 0.8×	120 0.4×	21	3.0k
Eugene Mahon Ireland	20	1.8k 1.7×	1.4k 1.4×	1.2k 1.6×	900 1.6×	370 1.3×	28	3.3k
Peisheng Xu United States	32	1.3k 1.3×	1.3k 1.3×	1.2k 1.6×	440 0.8×	226 0.8×	63	3.3k
Guangze Yang Australia	28	1.1k 1.0×	1.0k 1.0×	969 1.3×	520 0.9×	92 0.3×	62	2.9k

Countries citing papers authored by Verena Fetz

Since Specialization

Citations

This map shows the geographic impact of Verena Fetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Fetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Fetz more than expected).

Fields of papers citing papers by Verena Fetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Fetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Fetz. The network helps show where Verena Fetz may publish in the future.

Co-authorship network of co-authors of Verena Fetz

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Fetz. A scholar is included among the top collaborators of Verena Fetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Fetz. Verena Fetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fetz, Verena, et al.. (2023). Artificial Siderophores with a Trihydroxamate‐DOTAM Scaffold Deliver Iron and Antibiotic Cargo into the Bacterial Pathogen Escherichia coli. Israel Journal of Chemistry. 63(7-8). 1 indexed citations

Franke, Raimo, Verena Fetz, Theresia E. B. Stradal, et al.. (2019). xCELLanalyzer: A Framework for the Analysis of Cellular Impedance Measurements for Mode of Action Discovery. SLAS DISCOVERY. 24(3). 213–223. 5 indexed citations

Marx‐Stoelting, Philip, et al.. (2019). Caenorhabditis elegans As a Promising Alternative Model for Environmental Chemical Mixture Effect Assessment—A Comparative Study. Environmental Science & Technology. 53(21). 12725–12733. 48 indexed citations

Testolin, Giambattista, Katharina Rox, Hans Prochnow, et al.. (2019). Synthetic studies of cystobactamids as antibiotics and bacterial imaging carriers lead to compounds with high in vivo efficacy. Chemical Science. 11(5). 1316–1334. 28 indexed citations

Klahn, Philipp, Verena Fetz, Werner Tegge, et al.. (2019). The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates. Chemical Science. 10(20). 5197–5210. 9 indexed citations

Fetz, Verena, Xabier Murgia, Chiara Rossi, et al.. (2018). In Vitro Model of the Gram-Negative Bacterial Cell Envelope for Investigation of Anti-Infective Permeation Kinetics. ACS Infectious Diseases. 4(8). 1188–1196. 18 indexed citations

Dunst, Sebastian, Norman Ertych, Verena Fetz, et al.. (2017). The AOP Concept: How Novel Technologies Can Support Development of Adverse Outcome Pathways. 3(3). 271–277. 3 indexed citations

Fetz, Verena, Cecilia Vallet, Angelina Hahlbrock, et al.. (2017). TFIIA transcriptional activity is controlled by a ‘cleave-and-run’ Exportin-1/Taspase 1-switch. Journal of Molecular Cell Biology. 10(1). 33–47. 8 indexed citations

Fetz, Verena, Roland H. Stauber, & Shirley K. Knauer. (2017). Translocation Biosensors—Versatile Tools to Probe Protein Functions in Living Cells. Methods in molecular biology. 1683. 195–210. 1 indexed citations

10.

Hu, Hai‐Yu, et al.. (2017). Multivalent Siderophore–DOTAM Conjugates as Theranostics for Imaging and Treatment of Bacterial Infections. Angewandte Chemie International Edition. 56(28). 8272–8276. 78 indexed citations

11.

Nicolaou, K. C., Kiran Kumar Pulukuri, Stephan Rigol, et al.. (2016). Synthesis and Biological Investigation of Δ¹²-Prostaglandin J₃ (Δ¹²-PGJ₃) Analogues and Related Compounds. Journal of the American Chemical Society. 138(20). 6550–6560. 34 indexed citations

12.

Fahrer, Jörg, Verena Fetz, Roland H. Stauber, et al.. (2014). Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3. Cellular Signalling. 26(8). 1698–1706. 7 indexed citations

13.

Tenzer, Stefan, Dominic Docter, Jörg Kuharev, et al.. (2013). Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature Nanotechnology. 8(10). 772–781. 1809 indexed citations breakdown →

14.

Wünsch, Desirée, Verena Fetz, Dominik Heider, et al.. (2012). Chemico-genetic strategies to inhibit the leukemic potential of threonine aspartase-1. Blood Cancer Journal. 2(6). e77–e77. 14 indexed citations

15.

Knauer, Shirley K., Verena Fetz, Bettina Hofmann, et al.. (2011). Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors. PLoS ONE. 6(5). e18253–e18253. 20 indexed citations

16.

Stauber, Roland H., Desirée Wünsch, Shirley K. Knauer, & Verena Fetz. (2010). An update on the pathobiological relevance of nuclear receptors for cancers of the head and neck.. PubMed. 25(8). 1093–104. 9 indexed citations

17.

Fetz, Verena, Shirley K. Knauer, Carolin Bier, Jens Peter von Kries, & Roland H. Stauber. (2009). Translocation Biosensors – Cellular System Integrators to Dissect CRM1-Dependent Nuclear Export by Chemicogenomics. Sensors. 9(7). 5423–5445. 29 indexed citations

18.

Engels, Knut, Shirley K. Knauer, Sibylle Loibl, et al.. (2008). NO Signaling Confers Cytoprotectivity through the Survivin Network in Ovarian Carcinomas. Cancer Research. 68(13). 5159–5166. 64 indexed citations

19.

Fetz, Verena, Carolin Bier, Negusse Habtemichael, et al.. (2008). Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. International Journal of Cancer. 124(9). 2033–2041. 59 indexed citations

20.

Knauer, Shirley K., et al.. (2007). Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potential. International Journal of Cancer. 121(6). 1169–1174. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact